Draegerwerk Ag & Co. Kgaa · XETR:DRW8
Draegerwerk Ag & Co. Kgaa — Drägerwerk AG & Co. KGaA — FY2022 Earnings Presentation
20 slides from Draegerwerk Ag & Co. Kgaa's earnings presentation, Mar 9, 2023
Slide 1: Analyst Conference Drägerwerk AG & Co. KGaA
Analyst Conference Drägerwerk AG & Co. KGaA March 9, 2023, Lübeck
Slide 2: Disclaimer
Disclaimer This presentation does not constitute an offer of securities for sale or a solicitation of an offer to purchase any securities. No money, securities or other consideration is being solicited by this presentation. This presentation contains forward-looking statements regarding the future d
Slide 3: Dräger: Highlights 2022, Financials 2022, Outlook 2023
Dräger Highlights 2022 Financials 2022 Outlook 2023 3
Slide 4: Overview 2022
Overview 2022 Markets intact: growing demand for ›Technology for Life‹ Challenging economic conditions: global supply chain despite challenging economic conditions. disruptions, war in Ukraine, and high inflation. Attractive portfolio: lower demand for ventilators more than offset by Lower net sales
Slide 5: Babyroo TN300
A warm welcome after birth thanks to our new Babyroo TN300 − Configurable open care warmer with state-of-the- art thermoregulation capabilities − Support emergency resuscitation and family- centred care − Use in a variety of hospital environments along the patient pathway. The Babyroo supports effic
Slide 6: Access and Control Package
Reach the next level of patient monitoring with our new Access and Control Package − Increase flexibility and convenience when operating the Infinity M540 Patient Monitor − Reduce noise and stress at the bedside to improve patient comfort − Keep patients and staff safe in isolation scenarios With ou
Slide 7: X-am 2800
Another step into the digital future of occupational safety with the new X-am 2800 − Efficient data transmission, storage and analysis for e.g. live monitoring, equipment maintenance or fleet management, including firmware updates − Data transfer from X-am to smartphone and to Gas Detection Connect
Slide 8: Return to Growth and Profitability
RETURN TO GROWTH AND PROFITABILITY 01 02 03 04 05 Intact Improve Price Optimize Cost market growth delivery capability management free cash flow awareness Demand for Dräger Limited supply capability was The mandatory increase Improvement in free cash We are countering products increased the main rea
Slide 9: Financials Fiscal Year 2022
FINANCIALS Fiscal Year 2022
Slide 10: Dräger Group Financial performance
Dräger Group Financial performance Net Sales (in EUR million) EBIT (in EUR million) Highlights − Increased order entry: decline in ventilators -11.5% more than offset by other products and FX adjusted services. 8.2% -8.5% − Significant decline in net sales due to Margin Nominal limited availability
Slide 11: Dräger Group Key Figures
Drager Group Key Figures 12M 2022 12M 2021 Change € million € million % Cashflow (irom operating activities) 384.9 >-100 Investments 194.3 -32.7 Cash and cash equivalents’ 445.7 -30.1 Net financial debt’ -24.0 >+100 Net financial debt’ /EBITDA* -0.1 Capital employed’ 1,381.1 11.3 ROCE (€B!T?/ Capita
Slide 12: Medical division
Medical division Financial performance Order Entry Net Sales EBIT -0.5% -15.0% >-100% FX adjusted FX adjusted 9.3% +3.3% -11.8% EBIT- Nominal Nominal margin -5.0% EBIT- 1,917 1,979 2,064 1,822 191.6 margin 2022 2021 2022 2021 2022 2021 -90.4 Comments Q4 FY Order − Order entry on par with prior-year
Slide 13: Safety division
Safety division Financial performance Order Entry Net Sales EBIT +8.4% -5.8% -97.8% FX adjusted FX adjusted 6.3 +11.5% -3.2% EBIT- 1,171 1,305 1,264 1,224 margin Nominal Nominal 0.1% 80.0 EBIT- margin 1.8 2021 2022 2021 2022 2021 2022 Comments Q4 FY Order − Return to growth with significant increase
Slide 14: Simplification of the capital structure: Termination of participation certificates (1 of 2)
Simplification of the capital structure Termination of participation certificates (1 of 2) Distributable result 32% 100% Participation certificates Common & preferred shares Series A, series K, series D 5 Securities 2 Securities 68% Common & preferred shares 14
Slide 15: Simplification of the capital structure: Termination of participation certificates (2 of 2)
Simplification of the capital structure Termination of participation certificates (2 of 2) Termination of participation certificates Earnings per share In 2020, all 831,951 outstanding participation certificates were cancelled Pro forma as of December 2020, assuming full distribution and including d
Slide 16: Outlook Fiscal Year 2023
OUTLOOK Fiscal Year 2023
Slide 17: Dividend proposal for FY 2022
Dividend proposal for FY 2022 2021 (in EUR million) 2022 (in EUR million) Net profit / Net loss* 154.2 -64.6 Dividend 3.7 3.7 Participation certificates** 0.7 0.7 Common shares 1.3 1.3 Preferred shares 1.6 1.6 Net payout ratio 2.4% -5.7% Dividend per common share preferred share 0.13 € 0.13 €
Slide 18: Outlook FY 2023
Outlook FY 2023 2022 2023e Net Sales growth -11.5% 7.0 to 11.0%* (net of currency effects) Gross profit margin 40.7% 43.0 to 45.0% EBIT margin -2.9% 0.0 to 3.0% Dräger Value Added EUR -196.2m EUR -110 to 0m * Based on current spot rates corresponding to 5.5 – 9.5 % nominal growth 18
Slide 19: Questions & Answers
Questions & Answers Drager an “ Drager. Technology for Life®
Slide 20: Dräger. Technology for Life
Drager. Technology for Life®
Drägerwerk AG & Co. KGaA — FY2022 Earnings Presentation on 6ix